HighTower Advisors’s Amgen AMGN Stock Holding History

HighTower Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$2.77K	–	3761
2025 Q1	$2.77K	Sell	1,000 -600	-38%	-$177K	﹤0.01%	3613
2024 Q4	$6.4K	Buy	+1,600	New	+$475K	﹤0.01%	3615
2022 Q2	–	Sell	-1	Closed	-$11K	–	3231
2022 Q1	$11K	Buy	+1	New	+$230	﹤0.01%	3207
2014 Q3	–	Sell	-11,900	Closed	-$37K	–	1537
2014 Q2	$37K	Hold	11,900	–	–	﹤0.01%	1524
2014 Q1	$89K	Hold	11,900	–	–	﹤0.01%	1388
2013 Q4	$65K	Buy	11,900 +400	+3%	+$45.5K	﹤0.01%	1404
2013 Q3	$54K	Buy	+11,500	New	+$1.25M	﹤0.01%	1242

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HighTower Advisors's AMGN Position: Q1 2026 in Review

HighTower Advisors increased its Amgen (AMGN) stake by 4.3% in Q1 2026, buying an estimated $12M and bringing the position to 820,320 shares worth $289M. The position accounts for 0.31% of the portfolio, ranked #61.

HighTower Advisors first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

HighTower Advisors held 820,320 shares of Amgen worth $289M as of Q1 2026.
HighTower Advisors bought 33,696 Amgen shares in Q1 2026, an estimated $12M.
Amgen made up 0.31% of HighTower Advisors's portfolio in Q1 2026, its #61 holding.
HighTower Advisors first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.